Photograph of James K. Stronski

James K. Stronski

Senior Counsel


Jim Stronski is a senior counsel in the New York office of Crowell & Moring, and a member of the Intellectual Property Group. He also is a member of the Trade Secrets Working Group, and the Litigation & Trial Department. Jim is a first-chair trial lawyer who concentrates his practice in IP litigation and related commercial disputes, as well as advice on trademarks and related licensing issues and disputes. He has litigated in courts nationwide for over 25 years. Jim has been listed in the New York Super Lawyers Metro Edition for intellectual property litigation each year since 2006.

Jim’s practice includes patent litigation, trade secret litigation and counseling and trademark and false advertising litigation and counseling and copyright litigation. Jim also represents pharmaceutical companies concerning patent, regulatory and commercial obstacles to the commercialization of generic or biosimilar products, as well as in related commercial and licensing disputes.

Jim has first chaired cases at the PTO before the Trademark Trial and Appeal Board, including through trial, and advises clients on trademark infringement and clearance issues. Jim has served on the Editorial Board of the International Trademark Association's Trademark Reporter and has served as a moot court judge through several organizations, including the International Trademark Association. 

Jim serves on the firm’s Public Service Committee. He has been active representing individuals on death row, challenging convictions and challenging methods and protocols used in executions.  This work and the work of a many others at Crowell was recognized in the firm’s receipt of the 2018 Exceptional Service Award from the ABA’s Death Penalty Project

Jim was Law Clerk to the Honorable Judge Shirley Wohl Kram, U.S. District Court, Southern District of New York, from 1988-1990.

Education

  • Dartmouth College, B.A. (1984)
  • Fordham University School of Law, J.D. (1988)

Affiliations


Admitted to practice:
New York, U.S. Supreme Court, Courts of the State of New York, U.S. District Court for the Southern District of New York, U.S. District Court for the Eastern District of New York, U.S. Court of Appeals for the Federal Circuit, U.S. Court of Appeals for the Second Circuit

Professional Activities & Memberships
Jim is a member of several bar associations, including the Federal Bar Council and its Intellectual Property Committee and the Federal Bar Council's American Inn of Court where he serves as a Master.   

View More

Practices

Litigation & Trial

Intellectual Property Litigation

Commercial Litigation

Life Sciences

Advertising and Media

Pharmaceutical and Biologics Litigation

Trademark Counseling and Litigation

Antitrust and Competition Law

Pharmaceutical Industry and Prescription Drugs

Patent Litigation

Copyright Counseling and Litigation

Show more practices…

  • Secured a significant victory (a preliminary injunction against patent infringement through trial) on behalf of Lonza Walkersville, Inc. against Israel-based Adva Biotechnology Ltd. in a case involving point-of-care cell-therapy technology.
  • Waters Corporation, et al. v. Agilent Technologies, Inc., 18 civ. 01450 (MN), U.S. District Court for the District of Delaware, 2018 to present
  • Arch Chemicals, Inc. v. Sherwin Williams, 18 civ. 2037 (LPS), U.S. District Court for the District of Delaware, 2018 to present
  • Cellular Dynamics, Intl. v. Lonza Walkersville, 17 civ. 2713 (CCB), U.S. District Court for the District of Maryland, 2017 to present
  • Onyx Therapeutics v. CIPLA, Ltd., et al.,  16 civ 00988 (LPS), U.S. District Court for the District of Delaware, 2016 to 2019
  • Delcor Asset Corporation and Prestium Pharma, Inc. v. Taro Pharmaceutical Industries, Ltd., et al., No. 16-117-UNA, U.S. District Court for the District of Delaware, 2016 to 2017
  • In re CIPRODEX, Consolidated Civil Action No. 3:15-cv-05756 (PGS) (DEA), U.S. District Court for the District of New Jersey, 2016 to 2018
  • Noven Pharmaceuticals, Inc. v. Actavis Laboratories UT, Inc., No. 15-249-LPS, U.S. District Court for the District of Delaware, 2015 to present
  • Shenanzhu LLC d/b/a The Diner v. Cambria Company LLC, et al., 15 CV 00338 (WHP), U.S. District Court for the Southern District of New York, 2015 to 2017
  • Cephalon, Inc. v. Actavis Laboratories FL, Inc. et al., No.14-776-SLR-SRF, .U.S. District Court for the District of Delaware, 2014 to 2015
  • State of Ohio v. Apanovitch, CR 84: 194156, Court of Common Pleas, Cuyahoga County, Ohio, 2012 to present
  • Pfizer Inc. et al. v. Actavis Laboratories FL, Inc., No. 11-914, U.S. District Court for the District of Delaware, 2012-2014
  • Multilayer Stretch Cling Film Holdings, Inc. v. MSC Marketing and Technology, Inc., et al, No. 2:12 cv 02112, U.S. District Court for the Western District of Tennessee, 2012-2014
  • Takeda Pharmaceutical Co., Ltd et al. v. Handa Pharmaceuticals, LLC and Par Pharmaceutical, Inc., No. 3:11-840 U.S. District Court for the Northern District of California, 2012-2014
  • Handa Pharmaceuticals, LLC and Par Pharmaceutical, Inc. v. Takeda Pharmaceutical Co., Ltd et al. v., No. 5:13-1927, U.S. District Court for the Northern District of California, 2013-2014
  • Shire Development, LLC v. Watson Pharmaceuticals, Inc., U.S. District Court for the Southern District of Florida, 2012-2013
  • Sanofi Aventis US LLC, et al. V. Watson Pharmaceuticals, Inc., No. 1:2153 (SDW)(MCA), U.S. District Court for the District of New Jersey, 2011-2012
  • Cephalon, Inc. et al. v. Watson Pharmaceuticals, Inc. et al. (C.A. 08- 330-SLR; 09-724-SLR), U.S. District Court for the District of Delaware, 2008-2011
  • Purdue Pharma L.P. et al. v. Mallinckrodt, Inc. (06-CV-13095), U.S. District Court for the Southern District of New York, 2008
  • Reliant Pharmaceuticals, Inc. v. Par Pharmaceuticals, Inc. (C.A. 06-774- JJF), U.S. District Court for the District of Delaware, 2006-2008
  • Glaxo SmithKline v. Spectrum Pharmaceuticals (05-99-GMS; 06-0558-GMS), U.S. District Court for the District of Delaware, 2006
  • In re Rivastigmine Patent Litigation (MDL No. 1661), U.S. District Court for the Southern District of New York, 2004-2008
  • Pliant Corporation v. MSC Marketing & Technology, Inc. (04-CV-3509 (JBZ)), U.S. District Court for the Northern District of Illinois, 2004-2007
  • Cephalon, Inc. v. Carlsbad Technology, Inc. (05 CV 1089 (JCL)), U.S. District Court for the District of New Jersey, 2005-2006
  • Lambertson Truex, Inc. v. Sibeu Handbags, Inc. (03 Civ. 4510 (JES)), U.S. District Court for the Southern District of New York, 2003
  • Electronic Products Distribution, LLC v. Bio-Medical Research Ltd. (02 Civ. 00251 (JES)), U.S. District Court for the Southern District of New York, 2002-2005
  • Medichem S.A. v. Rolabo S.L. (01 Civ. 3087 (JSR)), U.S. District Court for the Southern District of New York, 2001-2007
  • Tokyo Electron Arizona, Inc. v. Discreet Industries Corporation, et al. (01-3245 (DRH)(WDW)), U.S. District Court for the Eastern District of New York, 2001-2004
  • Ocean Pacific Apparel Corp., v. Rays Apparel, Inc. (01 Civ. 7058 (KMW)), U.S. District Court for the Southern District of New York, 2001
  • Minnesota Mining and Manufacturing Co. and Riker Laboratories, Inc. v. Alphapharm Pty. Ltd. (99-0013 (MJD/JL)), U.S. District Court for the District of Minnesota, 1999-2002
  • SmithKline Beecham v. Watson Pharmaceuticals, et al. (99 Civ. 9214 (DC)), U.S. District Court for the Southern District of New York, 1999- 2000
  • Granutec, Inc. v. Shalala (97-485-5-BO), U.S. District Court for the Eastern District of North Carolina, 1997-1998
LITIGATION NOTE: Crowell & Moring Secures Preliminary Injunction for Lonza in Ground-Breaking Cell Therapy Patent Infringement Case (January 27, 2022)
Firm News / Announcement
"Early Focus On Damages Can Streamline Patent Litigation," Law360 (May 17, 2021). Authors: Robert B. Kornweiss, Anne Elise Herold Li, and James K. Stronski.
Publication
"The US Response to China's Theft and Acquisition of Trade Secrets," AIPLA CLE Webinar (January 13, 2021). Presenters: Caroline E. Brown and James K. Stronski.
Speech/Presentation
"Trade Secret Strategies: Using Standstill Agreements to Resolve Disputes Out of Court," Crowell & Moring’s Trade Secrets Trends (November 5, 2020). Authors: James K. Stronski, Anne Elise Herold Li and Robert B. Kornweiss.
Publication
"The U.S. Response to China’s Theft and Acquisition of Trade Secrets," Crowell & Moring Webinar (September 29, 2020). Presenters: Caroline E. Brown and James K. Stronski.
Speech/Presentation
"Trade Secret Protection During COVID-19 and Remote Working Environment: Identifying and Mitigating Risks, Limiting and Monitoring Third-Party Disclosures," Strafford Webinar (May 12, 2020). Presenters: Anne Elise Herold Li, James K. Stronski, and Robert B. Kornweiss.
Speech/Presentation
"Trade Secret Protection During the COVID-19 Pandemic," Crowell & Moring Webinar (May 6, 2020). Presenters: James K. Stronski, Anne Elise Herold Li, and Robert B. Kornweiss.
Speech/Presentation
"Coloring in the Lines – Protecting Colorful Product Packaging Just Became Easier," IP Insights (April 14, 2020). Contacts: Anne Elise Herold Li, James K. Stronski, David Ervin, Michelle Chipetine
Client Alert / Newsletter
"Trade Secret Protection During the COVID-19 Pandemic," Trade Secrets Alert (April 3, 2020). Contacts: James K. Stronski, Anne Elise Herold Li, Robert B. Kornweiss
Client Alert / Newsletter
"Top 10 Tips for Safeguarding Trade Secrets," Crowell & Moring Webinar (March 10, 2020). Presenters: Anne Elise Herold Li, James K. Stronski, and Robert B. Kornweiss.
Speech/Presentation

For all Highlights, News & Knowledge, please click here to view desktop bio.

Crowell & Moring LLP is an international law firm with offices in the United States, Europe, MENA, and Asia that represents clients in litigation and arbitration, regulatory and policy, and transactional and corporate matters. The firm is internationally recognized for its representation of Fortune 500 companies in high-stakes litigation and government-facing matters, as well as its ongoing commitment to pro bono service and diversity, equity, and inclusion.

View Desktop Site | Mobile Sitemap |

Contact | Subscribe | Terms of Use | Privacy Statement | Alumni

© Crowell & Moring LLP 2022
Attorney advertising - prior results do not guarantee a similar outcome.